Skip to content
★ Sign in to follow
RB

Rick Bierly

Executive
Impax Laboratories, LLCMedivation, Inc.
Total declarations
16
Companies
2
▲ Purchases (0 ops.)
—
▼ Sales (10 ops.)
€1.6M

Latest filing published 17 May 2017 for Impax Laboratories, LLC.

Insider track record

Disclosed buys
0
Disclosed sells
10
Signal history

Rick Bierly: trading record in brief

Filings by Rick Bierly span 2 companies, the busiest being Medivation, Inc. and Impax Laboratories, LLC. We count 16 filings; the first trade dates from 7 April 2014 and the latest from 16 May 2017.

On the market, this insider has only sold: 10 sales, €1.6M in total. The rest of the record consists of 5 share grants and 1 option exercise.

The record was last updated on 17 May 2017 with a share grant in Impax Laboratories, LLC. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Rick Bierly

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations16 total
  • ◆
    DirectorExecutivesImpax Laboratories, LLC
    0SEC
    4,375 shares0Common StockSEC:0001003642-17-000051:0
  • ◆
    DirectorExecutivesImpax Laboratories, LLC
    0SEC
    4,895 shares0Common StockSEC:0001003642-16-000026:0
  • ▼
    CFO (former)ExecutivesMedivation, Inc.
    238,280 USD22SEC
    4,025 shares@ US$59.2032.1% of flowCommon StockSEC:0001209191-16-118533:0
  • ▼
    CFO (former)ExecutivesMedivation, Inc.
    355,373 USD24SEC
    5,915 shares@ US$60.0847.8% of flowCommon StockSEC:0001209191-16-118533:1
  • ▼
    CFO (former)ExecutivesMedivation, Inc.
    24,264 USD19SEC
    400 shares@ US$60.663.3% of flowCommon StockSEC:0001209191-16-118533:2
  • ▼
    Chief Financial OfficerExecutivesMedivation, Inc.
    44,920 USD35SEC
    1,123 shares@ US$40.006.3% of flowCommon StockSEC:0001209191-16-106790:0
  • ▼
    Chief Financial OfficerExecutivesMedivation, Inc.
    75,000 USD35SEC
    1,875 shares@ US$40.0010.5% of flowCommon StockSEC:0001209191-16-106790:1
  • ◆
    Chief Financial OfficerExecutivesMedivation, Inc.
    0SEC
    12,400 shares0Common StockSEC:0001209191-16-104901:0
  • ▼
    Chief Financial OfficerExecutivesMedivation, Inc.
    130,000 USD0SEC
    1,000 shares@ US$130.00Common StockSEC:0001209191-15-045036:0
  • ▼
    Chief Financial OfficerExecutivesMedivation, Inc.
    48,125 USD0SEC
    385 shares@ US$125.00Common StockSEC:0001209191-15-041971:0
  • ▼
    Chief Financial OfficerExecutivesMedivation, Inc.
    270,599 USD0SEC
    2,170 shares@ US$124.70Common StockSEC:0001209191-15-039619:0
  • ▼
    Chief Financial OfficerExecutivesMedivation, Inc.
    201,875 USD0SEC
    1,615 shares@ US$125.00Common StockSEC:0001209191-15-039619:1
  • ◇
    Chief Financial OfficerExecutivesMedivation, Inc.
    174,300 USD0SEC
    3,000 shares@ US$58.10Common StockSEC:0001209191-15-034651:0
  • ▼
    Chief Financial OfficerExecutivesMedivation, Inc.
    396,600 USD0SEC
    3,000 shares@ US$132.20Common StockSEC:0001209191-15-034651:1
  • ◆
    Chief Financial OfficerExecutivesMedivation, Inc.
    0SEC
    4,500 shares0Common StockSEC:0001209191-15-012010:0
  • ◆
    Chief Financial OfficerExecutivesMedivation, Inc.
    0SEC
    15,511 shares0Common StockSEC:0001181431-14-015944:0

16 of 16 declarations